The Latest Breaking News from Hanna Sanoff

Rectal tumours disappear in experimental cancer drug trial, but too early to call it a cure

An experimental drug cleared tumours from a dozen people with a specific type of rectal cancer, but experts say there's loads more work to be done.

ABC News · Jun 10, 2022

Dostarlimab: How does promising cancer drug work?

‘This is the first time this has happened’: All 12 patients involved in US study entered remission after taking dostarlimab over a six-month period

The Independent UK · Jun 8, 2022

Experimental cancer drug 'cures almost every patient' in exciting trial

The drug dostarlimab appeared to cure every patient during a clinical trial at the Memorial Sloan Kettering Cancer Center (MSKCC) in New York

Dublin Live · Jun 8, 2022

Doctors amazed by experimental cancer drug that 'cures' every patient in trial

The drug, called dostarlimab, has apparently cured all 18 participants involved in its trial

Daily Record · Jun 7, 2022

Doctors amazed after 'game-changing' cancer drug 'cures' every patient in trial

The drug dostarlimab was given to 18 people with a type of rectal cancer every three weeks for six months in a study at the Memorial Sloan Kettering Cancer Center (MSKCC) in New York.

Edinburgh Live · Jun 7, 2022

Doctors left astonished as experimental cancer drug 'cures' every patient in trial

The drug dostarlimab was used in a trial at the Memorial Sloan Kettering Cancer Center (MSKCC) in New York where it cured all 18 participants with a form of rectal cancer

Daily Mirror · Jun 7, 2022